A
Atea Pharmaceuticals (AVIR)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Atea Pharmaceuticals (AVIR)
Atea Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing antiviral therapeutics to improve the lives of patients suffering from life-threatening viral infections.... Read more
- USD2.90
- USD2.93
- USD2.87
- USD5.19
- -6.50%
- --
- 458.09k
- 413.87k
- 238M
- 2.77
- -38.60%
Stock News
2 hours ago
Dow Jones Newswires: China’s Meituan plans share buyback valued at up to $1 billion
MarketWatch
yesterday
Key Words: 9 of Charlie Munger’s best investing lessons and words of wisdom
MarketWatch
yesterday
FA Center: ‘Wealth is really relative in the eyes of the beholder.’ You may not be as rich (or poor) as you think.
MarketWatch
yesterday
Market Extra: GameStop stock’s best day since January driven by fresh wave of speculative bets
MarketWatch
Unlock More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.
